(Q50449005)

14 March 2018

title

Metformin does not improve survival of cholangiocarcinoma patients with diabetes. (English)

1 reference

14 March 2018

0 references

1 reference

3

Rosebud O Roberts

1 reference

14 March 2018

author name string

Zhen Yang

1

1 reference

14 March 2018

Xiaodan Zhang

2

1 reference

14 March 2018

Lewis R Roberts

4

1 reference

14 March 2018

Roongruedee Chaiteerakij

5

1 reference

14 March 2018

language of work or name

English

0 references

publication date

1 April 2015

1 reference

14 March 2018

published in

Hepatology

1 reference

14 March 2018

volume

63

1 reference

14 March 2018

issue

2

1 reference

14 March 2018

page(s)

667-668

1 reference

14 March 2018

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27821

Crossref

reference URL

retrieved

21 January 2018

Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27821

Crossref

reference URL

retrieved

21 January 2018

Risk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27821

Crossref

reference URL

retrieved

21 January 2018

Identifiers

DOI

10.1002/HEP.27821

1 reference

14 March 2018

PubMed ID

25833233

1 reference

14 March 2018